

Request Sample Report
The global veterinary anti-infectives market is projected to reach a value of $10.5 billion by 2026, with a CAGR of 4.5%. Increasing pet ownership and rising incidences of infectious diseases among animals are driving market growth. The market is highly competitive, with key players focusing on strategic collaborations and product innovations. Request Sample Report
◍ Zoetis Animal Healthcare
◍ Merck
◍ Merial (Sanofi)
◍ Elanco
◍ Bayer Healthcare
◍ Ceva Animal Health
◍ Virbac
◍ Boehringer Ingelheim
The Veterinary Anti-infectives Market is highly competitive with key players such as Zoetis Animal Healthcare, Merck, Merial (Sanofi), Elanco, Bayer Healthcare, Ceva Animal Health, Virbac, and Boehringer Ingelheim. These companies offer a wide range of antiinfective products for various animal species, contributing to the growth of the market.
- Zoetis Animal Healthcare: $6.71 billion
- Merck: $10.79 billion
- Merial (Sanofi): $4.83 billion Request Sample Report
◍ Marbofloxacin
◍ Freeze-dried Ceftiofur ◍ Beta-lactams ◍ Oxytetracycline ◍ Aminosidine ◍ Companion Animals ◍ Farm Animals
◍ Florfenicol
Request Sample Report
Request Sample Report
$ X Billion USD